TAK-573, an anti-CD38-targeted attenuated interferon alpha (IFNα) fusion protein, showed anti-myeloma tumor responses in combination with standard of care (SOC) agents in multiple myeloma (MM) xenograft tumor models in vivo

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e116-e116
Main Authors: Fatholahi, Marjan, Valencia, Miriam, Mark, Armanini, Bi, Mingying, Syed, Sakeena, Zhang, Yuhong, Taura, Tetsuya, Yun, Yong, Wilson, David, Chattopadhyay, Nibedita, Bjorck, Pia, Curley, Michael, Sarah, Pogue
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.192